Pi080331050

Testing laboratory accredited by the DAP Deutsche Akkreditierungssystem Prüfwesen GmbH according to DIN EN ISO/IEC 17025. The accreditation is only valid for the test methods marked with (a). ANALYSIS REPORT No. 080402093
DATE: 02.04.2008
Green Card S.A.
Via Luserte sud 8
6572 QUARTINO
SCHWEIZ

Our reference no.
: PI080331050
: 60 % Royal Jelly Powder 40 % Longan fruit Powder - DG071012
Sample temp. when received / stored : Room temperature ANALYSIS REQUESTED: Chloramphenicol by Liquid Chromatography - Mass Spectrometry
n.d. - not detected < MRPL of 0.3 µg/kg (2003/181/EC dated 13.03.2003) (a) : accredited method. (A) : Inhouse procedure. This document may only be reproduced in full. The results given herein apply to the submitted sample only. Interpretation:
Regarding the examined parameters and the mentioned minimum required performance limit (MRPL) the sample
corresponds to the legal regulations (Decision 2003/181/EC dated March 13th, 2003 in connection
with the Decision 2005/34/EC dated January 11th, 2005).
Dr. Kurt-Peter RaezkeDipl.-Chemiker, Dr.rer.nat / Prüfleiter Testing laboratory accredited by the DAP Deutsche Akkreditierungssystem Prüfwesen GmbH according to DIN EN ISO/IEC 17025. The accreditation is only valid for the test methods marked with (a). ANALYSIS REPORT No. 080401070
DATE: 01.04.2008
Green Card S.A.
Via Luserte sud 8
6572 QUARTINO
SCHWEIZ

Our reference no.
: PI080331050
: 60 % Royal Jelly Powder 40 % Longan fruit Powder - DG071012
Sample temp. when received / stored : Room temperature ANALYSIS REQUESTED: Tetracyclines by Liquid Chromatography - Mass Spectrometry
n.d. - not detected < limit of quantification 10 µg/kg; n.a. - not analyzed (a) : accredited method. (A) : Inhouse procedure. This document may only be reproduced in full. The results given herein apply to the submitted sample only. Interpretation:
Regarding the examined parameters and the mentioned limit of quantification the sample corresponds
to the legal regulations (German ordinance about maximum residue levels RHmV dated 21/10/1999,
in connection with EU regulation (EEC) 2377/90 dated 26/06/1990).
Dr. Kurt-Peter RaezkeDipl.-Chemiker, Dr.rer.nat / Prüfleiter Testing laboratory accredited by the DAP Deutsche Akkreditierungssystem Prüfwesen GmbH according to DIN EN ISO/IEC 17025. The accreditation is only valid for the test methods marked with (a). ANALYSIS REPORT No. 080404234
DATE: 04.04.2008
Green Card S.A.
Via Luserte sud 8
6572 QUARTINO
SCHWEIZ

Our reference no.
: PI080331050
: 60 % Royal Jelly Powder 40 % Longan fruit Powder - DG071012
Sample temp. when received / stored : Room temperature ANALYSIS REQUESTED: Nitrofurane Metabolites by Liquid Chromatography - Mass Spectrometry
n.d. - not detected < 0.5 µg/kg MRPL (Minimum Required Performance limit) for nitrofurane metabolites = 1.0 µg/kg according to 2003/181/EG dated March 13, 2003 (A) : Inhouse procedure. This document may only be reproduced in full. The results given herein apply to the submitted sample only. Interpretation:
Regarding the examined parameters and the mentioned minimum required performance limit (MRPL) the sample
corresponds to the legal regulations (Decision 2003/181/EC dated March 13th, 2003 in connection
with the Decision 2005/34/EC dated January 11th, 2005).
Dr. Kurt-Peter RaezkeDipl.-Chemiker, Dr.rer.nat / Prüfleiter

Source: http://www.lafemmeroyale.ch/down/PI080331050.pdf

Microsoft word - spct2009e_clean.doc

OSTEOCIS ® TECHNICAL LEAFLET: SUMMARY OF PRODUCT CHARACTERISTICS TRADE NAME OF THE MEDICINAL PRODUCT Kit for the preparation of Technetium [99mTc] Oxidronate Injection QUALITATIVE AND QUANTITATIVE COMPOSITION OSTEOCIS®, kit for the preparation of Technetium [99mTc] Oxidronate Injection, consists of 5 multidose vials, each containing the following sterile, pyrogen-free, freeze

www1.saude.rs.gov.br

Porto Alegre, quarta-feira, 12 de dezembro de 2007 DIÁRIO OFICIAL Anexo II: Requisitos Mínimos de Apresentação dos LaudosNa 1ª Fase do programa serão selecionados cinco medicamentos, enquadrados entre os mais manipulados e medicamentos sujeitos a controle Especial (Port. 344/98), na forma farmacêutica de Os critérios para a coleta dos medicamentos nas fases seguintes serão estabelec

Copyright © 2010-2014 Medical Articles